Sarah Cianférani Selected Research

Sarah Cianférani Research Topics

12	Neoplasms (Cancer) 05/2024 - 01/2014
4	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2015
3	Inflammation (Inflammations) 03/2024 - 09/2020
3	Bacillary Dysentery (Shigellosis) 11/2020 - 01/2017
2	Multiple Sclerosis 01/2022 - 01/2018
1	Reperfusion Injury 11/2022
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 10/2022
1	Rare Diseases (Rare Disease) 10/2022
1	Fibrosis (Cirrhosis) 10/2022
1	Malaria 05/2021
1	Infections 06/2020
1	Friedreich Ataxia (Friedreich's Ataxia) 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Phenylketonurias (Phenylketonuria) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2014

3	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2019
3	EnzymesIBA 01/2022 - 01/2018
3	Monoclonal AntibodiesIBA 10/2021 - 01/2016
3	Immunoconjugates (Immunoconjugate)IBA 05/2021 - 01/2016
2	Bispecific AntibodiesIBA 05/2024 - 11/2023
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 08/2015
2	queuine tRNA-ribosyltransferaseIBA 01/2018 - 01/2017
1	RNA (Ribonucleic Acid)IBA 03/2024
1	Small Interfering RNA (siRNA)IBA 03/2024
1	CytokinesIBA 03/2024
1	InterferonsIBA 03/2024
1	AntibodiesIBA 11/2023
1	Tyrosine (L-Tyrosine)FDA Link 11/2023
1	Immunoglobulin G (IgG)IBA 11/2023
1	AntigensIBA 11/2023
1	Digoxin (Digitek)FDA LinkGeneric 11/2022
1	Transcription Factors (Transcription Factor)IBA 10/2022
1	plasmodioneIBA 05/2021
1	Antimalarials (Antimalarial Agents)IBA 05/2021
1	SuspensionsIBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 09/2020
1	DNA (Deoxyribonucleic Acid)IBA 06/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	monomethyl auristatin EIBA 01/2020
1	AlbuminsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2019
1	S100 Proteins (S 100 Protein)IBA 01/2019
1	SulfurIBA 01/2019
1	IronIBA 01/2019
1	HexokinaseIBA 01/2019
1	FrataxinIBA 01/2019
1	Actin Depolymerizing Factors (Cofilins)IBA 01/2018
1	sapropterin (tetrahydrobiopterin)FDA Link 01/2018
1	Transfer RNA (tRNA)IBA 01/2018
1	Ado-Trastuzumab EmtansineIBA 12/2017
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2016
1	human ERBB2 proteinIBA 08/2015
1	Lysine (L-Lysine)FDA Link 08/2015
1	Maytansine (Maitansine)IBA 08/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2014